Yuki Hoshino

Saitama Medical University

H指数:23

被引数:1,746

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transverse facial cleft repair: Preventing pigmentation around the postoperative scar by excising the pigmented white lip at the cleft margin-A retrospective case series of Japanese patients

横面裂修复：通过切除裂缘色素性白唇以预防术后疤痕周围色素沉着——一项日本患者回顾性病例系列研究

JPRAS Open

IF1.8

2026-05-010

Association of tumor CD73 expression with clinical outcomes in small cell lung cancer treated with first-line chemo-immunotherapy

小细胞肺癌一线化疗联合免疫治疗后肿瘤CD73表达与临床结局的相关性

Lung Cancer

IF4.4

2026-04-250

OAAI

Effects of sublingual allergen immunotherapy on non-targeted allergen-induced immune responses

舌下过敏原免疫疗法对非靶向过敏原诱导的免疫反应的影响

Allergology International

IF6.7

2026-01-010

OAAI

Surgical Outcomes of Submucous Cleft Palate Using Intravelar Veloplasty with a Buccinator Musculomucosal Flap: A Case Series

黏膜下腭裂使用帆状腭帆成形术结合颊肌黏膜瓣的手术效果：一个病例系列

Cleft Palate Craniofacial Journal

IF1.3

2025-12-010

PRE

Hereditary Neuropathy with Liability to Pressure Palsies Unmasked by Polatuzumab Vedotin-containing Chemotherapy

遗传性压迫性神经病易感性由含polatuzumab vedotin的化疗引发

INTERNAL MEDICINE

IF1.1

2025-11-010

PRE

Effect of the Combination of Concomitant Drugs on Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Cancer Reports

IF1.9

2025-11-010

OAAI

Real-World Experience with FcRn Inhibitors Efgartigimod and Rozanolixizumab in Myasthenia Gravis: Administration in Multiple Cycles and Transition from Intravenous to Subcutaneous Formulation

真实世界经验：重症肌无力患者使用FcRn抑制剂Efgartigimod和Rozanolixizumab的多周期给药及从静脉注射到皮下制剂的转换

NEUROLOGY AND THERAPY

IF4.8

2025-04-210

N-Oxide-Catalyzed Six-Membered Ring Bromo-Etherification of ϵ-Alkenyl Alcohols

ADVANCED SYNTHESIS & CATALYSIS

IF4

2024-11-200

PRE

Elevated serum IL-36 subfamily levels impact on asthma control

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Achievement of clinical remission in asthma subgroups based on the combination of FeNO and blood eosinophil counts

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Dupilumab may be beneficial for severe asthma patients with high FeNO And low blood eosinophil counts in real world observational study.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Plasma IL-36 subfamily levels impact on clinical manifestations of asthma

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Fibrinogen Aα-chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease model

JOURNAL OF PATHOLOGY

IF5.2

2023-08-074

Molecular design of near-infrared (NIR) fluorescent probes targeting exopeptidase and application for detection of dipeptidyl peptidase 4 (DPP-4) activity

RSC CHEMICAL BIOLOGY

IF3.1

2022-01-018

OAAI

Fractionation of hops-extract ethanol solutions using dense CO2 with a counter-current extraction column

使用稠密的CO2和逆流萃取柱对啤酒花提取物乙醇溶液进行分馏

JOURNAL OF SUPERCRITICAL FLUIDS

IF4.4

2018-06-0114

PREAI

Circulating microRNA-214 and-126 as potential biomarkers for canine neoplastic disease

SCIENTIFIC REPORTS

IF3.9

2017-05-2344

OAAI

Supramolecular Polymer of Near-Infrared Luminescent Porphyrin Glass

MACROMOLECULES

IF5.2

2017-04-0517

PREAI

Urinary exosome-derived microRNAs reflecting the changes of renal function and histopathology in dogs

SCIENTIFIC REPORTS

IF3.9

2017-01-1145

OAAI

A metal-lustrous porphyrin foil

CHEMICAL COMMUNICATIONS

IF4.2

2017-01-0122

PREAI

Rhodium(III)-Catalyzed Tandem [2+2+2] Annulation-Lactamization of Anilides with Two Alkynoates via Cleavage of Two Adjacent C-H or C-H/C-O bonds

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2016-08-0927

PREAI

Yuki Hoshino

个人简介

教育背景

工作经历

荣誉奖项

研究方向